🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05663281
Recruiting Observational

Thrombus Imaging and Treatment Analytics in Neurology

NCT05663281 · tracked via the Priya Life Science China tracker
Sponsor
Chinese PLA General Hospital
Phase
Observational
Started
2022-12-15
Last updated
2024-07-03

Condition(s) studied

Thrombus, BrainThrombosis

Investigational drug(s) / intervention(s)

thrombus imaging appearance

thrombus imaging appearance: Imaging appearance of intracranial and/or extracranial arterial thrombus

Study summary

In the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to investigate the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Extracranial and/or intracranial artery occlusion confirmed by angiography * Available for magnetic resonance high-resolution vessel wall imaging * Written informed consent obtained Exclusion Criteria: * Extracranial and/or intracranial artery mild to moderate stenosis * Pregnant women * Restenosis or occlusion after artery stenting placement

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chinese PLA General Hospital Beijing Beijing Municipality Recruiting

More Chinese PLA General Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05663281 on ClinicalTrials.gov ↗ ← All trials in China